Related Experiment Videos
Motoric behavior in aged rats treated with GM1
V M Goettl1, T A Wemlinger, A E Colvin
1Department of Pharmacology, The Ohio State University College of Medicine and Public Health, Columbus, OH 43210, USA.
Brain Research
|June 30, 2001
Summary
GM1 ganglioside partially restored aged nigrostriatal neurons but did not improve motor deficits in rats. Further research is needed to enhance motor function recovery in aging.
Area of Science:
- Neuroscience
- Aging Research
- Pharmacology
Background:
- Aging impairs motor function, partly due to nigrostriatal dopaminergic neuron degeneration.
- GM1 ganglioside has shown potential in restoring dopaminergic markers and neuron morphology in aged rats.
Purpose of the Study:
- To investigate the effects of GM1 ganglioside treatment on motor activity, coordination, balance, and strength in aged rats.
- To determine if GM1 treatment can ameliorate age-associated motor deficits.
Main Methods:
- Aged Sprague-Dawley rats received daily intraperitoneal injections of GM1 ganglioside (30 mg/kg) for 36 days.
- Locomotor and stereotypic activity, coordination (square bridge test, inclined screen, rod suspension), and balance were assessed.
- Dopamine and homovanillic acid content, as well as D1 and D2 dopamine receptor binding and mRNA levels, were analyzed in nigrostriatal neurons and striatum.
Main Results:
- GM1 treatment did not improve overall locomotor or stereotypic behavior in aged rats.
- Partial improvement was observed in the square bridge test, but not in inclined screen or rod suspension tests.
- GM1 restored dopamine and homovanillic acid levels but did not affect reduced D1/D2 dopamine receptor binding or mRNA in the striatum.
Conclusions:
- Despite partial morphological and metabolic restoration of nigrostriatal neurons, GM1 ganglioside has limited efficacy in improving age-associated motor deficits.
- The lack of improvement in motor function may be linked to unchanged dopamine receptor levels.